Plain-English translation of NCT02487095 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Read our Ovarian cancer research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
United States
Phase
Safety & dosing / Early efficacy
Sponsor
National Cancer Institute (NCI)
Enrollment target
~62 participants
Started
July 2015
Primary completion
February 2021
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.